Gene: SLC45A3
Official Full Name: solute carrier family 45 member 3provided by HGNC
Gene Summary: Predicted to enable sucrose:proton symporter activity. Predicted to be involved in positive regulation of small molecule metabolic process; regulation of oligodendrocyte differentiation; and sucrose transport. Predicted to be located in plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03917 | SLC45A3 Knockout cell line (HeLa) | Human | SLC45A3 | 1:3~1:6 | Negative | Online Inquiry |
KO03918 | SLC45A3 Knockout cell line (HCT 116) | Human | SLC45A3 | 1:2~1:4 | Negative | Online Inquiry |
KO03919 | SLC45A3 Knockout cell line (HEK293) | Human | SLC45A3 | 1:3~1:6 | Negative | Online Inquiry |
KO03920 | SLC45A3 Knockout cell line (A549) | Human | SLC45A3 | 1:3~1:4 | Negative | Online Inquiry |
SLC45A3 Gene Knockout Cell Lines are genetically engineered cellular models designed to specifically disrupt the SLC45A3 gene, which encodes a protein implicated in various biological processes, including cell proliferation and metabolic regulation. This innovative product allows researchers to explore the role of the SLC45A3 gene in health and disease, providing an essential tool for understanding the intricate mechanisms of cellular function and pathology.
The key function of these knockout cell lines lies in their ability to elucidate the biological significance of SLC45A3. By removing this gene's expression, investigators can study the resultant phenotypic changes, alterations in signaling pathways, and the impact on cellular behavior. Mechanistically, the absence of SLC45A3 may disrupt specific ion transport functions and metabolic pathways, leading researchers to uncover new insights into metabolic disorders and cancer biology.
The scientific importance of SLC45A3 Gene Knockout Cell Lines is evidenced by their potential applications in both fundamental research and clinical settings. They serve as vital platforms for drug discovery, disease modeling, and therapeutic target validation. Clinically, understanding SLC45A3-related pathways could pave the way for innovative strategies in treating various malignancies where this gene is implicated.
Compared to alternatives such as transient knockdown methodologies, knockout cell lines offer long-term stability and consistency, making them superior for sequential experimentation and functional validation. Their specificity reduces off-target effects, thereby enhancing the accuracy of experimental outcomes.
For researchers and clinicians aiming to advance their understanding of SLC45A3-related mechanisms, these cell lines represent a valuable asset that encourages groundbreaking discoveries and innovative approaches in medical research. Our company is dedicated to providing high-quality, scientifically validated biotechnological products, and the SLC45A3 Gene Knockout Cell Lines exemplify our commitment to facilitating cutting-edge research and enhancing experimental precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.